Randomised clinical trial: a 1‐week, double‐blind, placebo‐controlled study of pancreatin 25 000 Ph. Eur. minimicrospheres (Creon 25000 MMS) for pancreatic exocrine insufficiency after pancreatic surgery, with a 1‐year open‐label extension
Alimentary Pharmacology & Therapeutics2013Vol. 37(7), pp. 691–702
Citations Over TimeTop 10% of 2013 papers
Carola Seiler, Jakob R. Izbicki, Lajos Varga-Szabó, László Czakó, János Fiók, Cosimo Sperti, Markus M. Lerch, Raffaele Pezzilli, G. A. VASIL'EVA, Á. Pap, Márta Varga, Helmut Friess
Abstract
This study demonstrates superior efficacy of pancreatin 25 000 over placebo in patients with PEI after pancreatic surgery, measured by change in CFA. Pancreatin was generally well tolerated at the high dose administered (EudraCT registration number: 2005-004854-29).
Related Papers
- → Review article Flatulence — Causes, relation to diet and remedies(1988)130 cited
- → Flatulence in pet dogs(1998)5 cited
- → The effect of chamomile on flatulence after the laparoscopic cholecystectomy: A randomized triple-blind placebo-controlled clinical trial(2023)2 cited
- → CARBOHYDRATES IN DIET AND FLATULENCE(1942)
- [Basal fecal fermentation and with lactulose in patients with flatulence].(2004)